Centene ( (CNC) ) has released its Q4 earnings. Here is a breakdown of the information Centene presented to its investors.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Centene Corporation is a leading healthcare enterprise that provides integrated healthcare services to government-sponsored and commercial healthcare programs, focusing primarily on under-insured and uninsured individuals across the United States.
The company recently announced its financial results for the year 2024, highlighting a 7% increase in adjusted diluted earnings per share (EPS) to $7.17 from $6.68 in 2023. Membership saw significant growth in both Marketplace and Medicare Prescription Drug Plan (PDP) sectors, with respective increases of 12% and 50%.
Key financial metrics included total revenues of $163.1 billion for the year, marking a 4% increase from the previous year, driven by membership growth in Marketplace and rate increases in Medicaid. The company executed $3 billion in share repurchases, highlighting strong capital deployment. Centene’s operating expenses were carefully managed, with a decrease in the SG&A expense ratio to 8.5%, reflecting efficient cost management.
Looking forward, Centene has increased its 2025 premium and service revenues guidance by $4 billion due to strong enrollment performances and anticipated Medicaid revenue enhancements. The company remains optimistic about its diversified platform and its potential to deliver value across its core businesses.
Centene’s management has expressed confidence in continuing to transform the health of the communities they serve, leveraging their operational improvements and enhanced membership positioning.
